Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?

J Haas, E Zilberberg, R Machtinger… - Gynecological …, 2015 - Taylor & Francis
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …

Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?

J Haas, E Zilberberg, R Machtinger, A Kedem… - Gynecological …, 2015 - cris.bgu.ac.il
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …

Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?

J Haas, E Zilberberg, R Machtinger… - … : the official journal …, 2015 - pubmed.ncbi.nlm.nih.gov
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …

Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?

J Haas, E Zilberberg, R Machtinger… - … : the Official Journal of …, 2014 - europepmc.org
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …